The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
The Nuclear Dot Protein Sp100, Characterization of Domains Necessary for Dimerization, Subcellular Localization, and Modification by Small Ubiquitin-like Modifiers
Open accessAbstract
The Sp100 and promyelocytic leukemia proteins (PML) are constituents of nuclear domains, known as nuclear dots (NDs) or PML bodies, and are both covalently modified by the small ubiquitin-related protein SUMO-1. NDs play a role in autoimmunity, virus infections, and in the etiology of acute promyelocytic leukemia. To date, little is known about the function of the Sp100 protein. Here we analyzed Sp100 domains that determine its subcellular localization, dimerization, and SUMOylation. A functional nuclear localization signal and an ND-targeting region that coincides with an Sp100 homodimerization domain were mapped. Sequences similar to the Sp100 homodimerization/ND-targeting region occur in several other proteins and constitute a novel protein motif, termed HSR domain. The lysine residue of the Sp100 protein, to which SUMO-1 is covalently linked, was mapped within and may therefore modulate the previously described HP1 protein-binding site. A consensus sequence for SUMOylation of proteins in general is suggested. SUMOylation strictly depended on a functional nuclear localization signal but was not necessary for nuclear import or ND targeting. A three-dimensional structure of Sp100, which supports the mapping data and provides additional information on Sp100 structure/function relationships, was generated by computer modeling. Taken together, our studies indicate the existence of well defined Sp100 domains with functions in ND targeting, nuclear import, nuclear SUMOylation, and protein-protein interaction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
de Thé, H., Chomienne, C., Lanotte, M., Degos, L., & Dejean, A. (1990) · Nature · doi:10.1038/347558a0 · Cited by 1,355
Aaltonen, J., Björses, P., Perheentupa, J., Horelli–Kuitunen, N., Palotie, A., Peltonen, L., Lee, Y. S., Francis, F., Henning, S., Thiel, C., et al. (1997) · Nature Genetics · doi:10.1038/ng1297-399 · Cited by 1,228
Matunis, M. J., Coutavas, E., & Blobel, G. (1996) · The Journal of cell biology · doi:10.1083/jcb.135.6.1457 · Cited by 1,197
SUMO-1 Modification of IκBα Inhibits NF-κB Activation
Desterro, J. M. P., Rodriguez, M. S., & Hay, R. T. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80133-1 · Cited by 1,038
Structure and Function in the Nucleus
Lamond, A. I., & Earnshaw, W. C. (1998) · Science · doi:10.1126/science.280.5363.547 · Cited by 923
Chen, G., Zhu, J., Shi, X., Ni, J., Zhong, H., Si, G., Jin, X., Tang, W., Li, X., Xong, S., et al. (1996) · Blood · doi:10.1182/blood.v88.3.1052.1052 · Cited by 864
A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein
Dyck, J. A., Maul, G. G., Miller, W. H., Chen, J. D., Kakizuka, A., & Evans, R. M. (1994) · Cell · doi:10.1016/0092-8674(94)90340-9 · Cited by 785
Muller, S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.1.61 · Cited by 674
A versatile in vivo and in vitro eukaryotic expression vector for protein engineering
Green, S., Issemann, I., & Sheer, E. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.1.369 · Cited by 666
Weis, K., Rambaud, S., Lavau, C., Jansen, J., Carvalho, T., Carmo-Fonseca, M., Lamond, A., & Dejean, A. (1994) · Cell · doi:10.1016/0092-8674(94)90341-7 · Cited by 652
Cited by
Concepts in sumoylation: a decade on
Geiss-Friedlander, R., & Melchior, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2293 · Cited by 1,785
Johnson, E. S. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.074118 · Cited by 1,675
Sumoylation: A Regulatory Protein Modification in Health and Disease
Flotho, A., & Melchior, F. (2013) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061909-093311 · Cited by 1,097
The Nucleoporin RanBP2 Has SUMO1 E3 Ligase Activity
Pichler, A., Gast, A., Seeler, J. S., Dejean, A., & Melchior, F. (2002) · Cell · doi:10.1016/s0092-8674(01)00633-x · Cited by 816
Melchior, F. (2000) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.16.1.591 · Cited by 774
Sumo, ubiquitin's mysterious cousin
Müller, S., Hoege, C., Pyrowolakis, G., & Jentsch, S. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35056591 · Cited by 764
SUMO and ubiquitin in the nucleus: different functions, similar mechanisms?
Gill, G. (2004) · Genes & Development · doi:10.1101/gad.1214604 · Cited by 756
SUMO-1 Conjugation in Vivo Requires Both a Consensus Modification Motif and Nuclear Targeting
Rodriguez, M. S., Dargemont, C., & Hay, R. T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009476200 · Cited by 744
Nuclear and unclear functions of SUMO
Seeler, J.-S., & Dejean, A. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1200 · Cited by 667
The transcriptional role of PML and the nuclear body
Zhong, S., Salomoni, P., & Pandolfi, P. P. (2000) · Nature Cell Biology · doi:10.1038/35010583 · Cited by 577
Role of SUMO-1–modified PML in nuclear body formation
Zhong, S., Müller, S., Ronchetti, S., Freemont, P. S., Dejean, A., & Pandolfi, P. P. (2000) · Blood · doi:10.1182/blood.v95.9.2748.009k31a_2748_2752 · Cited by 561
Sampson, D. A., Wang, M., & Matunis, M. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100006200 · Cited by 519
Ipr1 gene mediates innate immunity to tuberculosis
Pan, H., Yan, B.-S., Rojas, M., Shebzukhov, Y. V., Zhou, H., Kobzik, L., Higgins, D. E., Daly, M. J., Bloom, B. R., & Kramnik, I. (2005) · Nature · doi:10.1038/nature03419 · Cited by 480
Ubiquitin-like proteins: new wines in new bottles
Yeh, E. T. H., Gong, L., & Kamitani, T. (2000) · Gene · doi:10.1016/s0378-1119(00)00139-6 · Cited by 469
Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1)
Poukka, H., Karvonen, U., Jänne, O. A., & Palvimo, J. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.26.14145 · Cited by 457
PML and PML nuclear bodies: Implications in antiviral defence
Everett, R. D., & Chelbi-Alix, M. K. (2007) · Biochimie · doi:10.1016/j.biochi.2007.01.004 · Cited by 439
PIAS Proteins Modulate Transcription Factors by Functioning as SUMO-1 Ligases
Kotaja, N., Karvonen, U., Jänne, O. A., & Palvimo, J. J. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.14.5222-5234.2002 · Cited by 425
Covalent Modification of p73α by SUMO-1
Minty, A., Dumont, X., Kaghad, M., & Caput, D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004293200 · Cited by 388
Cell Cycle–Regulated Attachment of the Ubiquitin-Related Protein Sumo to the Yeast Septins
Johnson, E. S., & Blobel, G. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.5.981 · Cited by 381
Regulation of p53 activity in nuclear bodies by a specific PML isoform
Fogal, V. (2000) · The EMBO Journal · doi:10.1093/emboj/19.22.6185 · Cited by 372
Björses, P., Halonen, M., Palvimo, J. J., Kolmer, M., Aaltonen, J., Ellonen, P., Perheentupa, J., Ulmanen, I., & Peltonen, L. (2000) · The American Journal of Human Genetics · doi:10.1086/302765 · Cited by 361
Biological Sequence Motif Discovery Using motif‐x
Chou, M. F., & Schwartz, D. (2011) · Current Protocols in Bioinformatics · doi:10.1002/0471250953.bi1315s35 · Cited by 347
Understanding eukaryotic linear motifs and their role in cell signaling and regulation
Diella, F. (2008) · Frontiers in Bioscience · doi:10.2741/3175 · Cited by 340
Circadian Clock Control by SUMOylation of BMAL1
Cardone, L., Hirayama, J., Giordano, F., Tamaru, T., Palvimo, J. J., & Sassone-Corsi, P. (2005) · Science · doi:10.1126/science.1110689 · Cited by 329
Review: Properties and Assembly Mechanisms of ND10, PML Bodies, or PODs
Maul, G. G., Negorev, D., Bell, P., & Ishov, A. M. (2000) · Journal of Structural Biology · doi:10.1006/jsbi.2000.4239 · Cited by 287
Promyelocytic Leukemia (Pml) Nuclear Bodies Are Protein Structures That Do Not Accumulate RNA
Boisvert, F.-M., Hendzel, M. J., & Bazett-Jones, D. P. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.2.283 · Cited by 276
Jürgen Dohmen, R. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2004.09.021 · Cited by 270
Apg10p, a novel protein‐conjugating enzyme essential for autophagy in yeast
Shintani, T., Mizushima, N., Ogawa, Y., Matsuura, A., Noda, T., & Ohsumi, Y. (1999) · The EMBO Journal · doi:10.1093/emboj/18.19.5234 · Cited by 269
Buschmann, T., Fuchs, S. Y., Lee, C.-G., Pan, Z.-Q., & Ronai, Z. (2000) · Cell · doi:10.1016/s0092-8674(00)80887-9 · Cited by 269
RetractedTranscription factor Sp3 is silenced through SUMO modification by PIAS1
Sapetschnig, A., Rischitor, G., Braun, H., Doll, A., Schergaut, M., Melchior, F., & Suske, G. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf510 · Cited by 262
Negorev, D., & Maul, G. G. (2001) · Oncogene · doi:10.1038/sj.onc.1204764 · Cited by 258
Comerford, K. M., Leonard, M. O., Karhausen, J., Carey, R., Colgan, S. P., & Taylor, C. T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337412100 · Cited by 185
Metadata
- Authors
- Sternsdorf, T., Jensen, K., Reich, B., & Will, H.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1999-04
- Volume
- 274
- Issue
- 18
- Pages
- 12555-12566
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1988841577
- Cited by
- 264
- References
- 58
- FWCI
- 7.61
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.